Pfizer commissions vaccine plant in Turkey

Zaman – Global pharmaceutical company Pfizer opened a pneumococcal conjugate vaccine (PCV) production plant in Istanbul, making Turkey the third country after the US and Ireland to host such a facility. The global giant cooperated with Mefar Ilac under Birgi Mefar Group for the plant located in Istanbul’s Pendik district.

The facility has the capacity to produce 75 million doses annually, allowing the country to become self-sufficient in the supply of the vaccine for infants and young children against pneumococcal diseases. The local production of such vaccines constitutes a key element of the country’s Childhood National Immunization Program run by the Ministry of Health.

Pfizer’s Turkish unit manufactures 70 percent of its products on the market locally and exports to 18 countries.

turkey; healthcare sector; turkey pharma market; turkey national immunization program; turkey national vaccination program; Pfizer turkey; turkey pcv vaccine; turkey vaccine production